Literature DB >> 34606629

Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.

Heather M Brandt1, Deanna Kepka2, Anne C Kirchhoff3, Casey L Daniel4, Neel S Bhatt5.   

Abstract

Entities:  

Keywords:  HPV vaccination; HPV vaccine; childhood cancer; human papillomavirus; oncology; survivorship; survivorship guidelines; vaccination

Mesh：

Year:  2021        PMID： 34606629      PMCID： PMC8738104          DOI： 10.1002/cncr.33920

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  19 in total

1.  Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer.

Authors:  James L Klosky; Kathryn M Russell; Jessica L Simmons; Rebecca H Foster; Kelly Peck; Daniel M Green; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2015-04-20       Impact factor: 3.167

2.  Human Papillomavirus Vaccine Is Crucial for Adolescent and Young Adult Cancer Survivors.

Authors:  Brooke Cherven; Wendy Landier
Journal:  J Adolesc Young Adult Oncol       Date:  2017-06-08       Impact factor: 2.223

3.  Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors.

Authors:  Brooke Cherven; Sharon M Castellino; Yanjun Chen; F Lennie Wong; Jocelyn M York; Karen Wasilewski-Masker; Melissa M Hudson; Smita Bhatia; James L Klosky; Wendy Landier
Journal:  Cancer       Date:  2019-07-10       Impact factor: 6.860

4.  Human Papillomavirus Vaccination Rates in Young Cancer Survivors.

Authors:  James L Klosky; Melissa M Hudson; Yanjun Chen; James A Connelly; Karen Wasilewski-Masker; Can-Lan Sun; Liton Francisco; Laura Gustafson; Kathryn M Russell; Gina Sabbatini; Jessica S Flynn; Jocelyn M York; Anna R Giuliano; Leslie L Robison; F Lennie Wong; Smita Bhatia; Wendy Landier
Journal:  J Clin Oncol       Date:  2017-08-24       Impact factor: 44.544

5.  Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers.

Authors:  Teresa M Imburgia; Marcia L Shew; Patti E Gravitt; Rachel A Katzenellenbogen
Journal:  Transplantation       Date:  2021-04-01       Impact factor: 4.939

6.  Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.

Authors:  Tara O Henderson; Brynn W Fowler; Haley A Hamann; Paul C Nathan; Jillian Whitton; Wendy M Leisenring; Kevin C Oeffinger; Joseph P Neglia; Lucie M Turcotte; Michael A Arnold; Miriam R Conces; Rebecca M Howell; Leslie L Robison; Gregory T Armstrong; Kenneth A Alexander
Journal:  Cancer       Date:  2021-10-04       Impact factor: 6.860

7.  HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors.

Authors:  Austin R Waters; Karely Mann; Perla L Vaca Lopez; Deanna Kepka; Yelena P Wu; Anne C Kirchhoff
Journal:  J Cancer Educ       Date:  2021-03-19       Impact factor: 1.771

8.  HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors.

Authors:  Anne C Kirchhoff; Karely Mann; Echo L Warner; Heydon K Kaddas; Douglas Fair; Mark Fluchel; Elizabeth D Knackstedt; Deanna Kepka
Journal:  Hum Vaccin Immunother       Date:  2019-06-25       Impact factor: 3.452

9.  Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Elissa Meites; Peter G Szilagyi; Harrell W Chesson; Elizabeth R Unger; José R Romero; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-08-16       Impact factor: 17.586

10.  Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers.

Authors:  Rohit P Ojha; Joseph E Tota; Tabatha N Offutt-Powell; James L Klosky; Timothy D Minniear; Bradford E Jackson; James G Gurney
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.